Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.
- NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_assertion description "[Multiple logistic regression analysis identified longer duration of hospitalisation [odds ratio (OR): 1.78; OR: 2.83 for >or=20 days], intra-hospital transfer (OR: 1.91), non-infectious skin conditions (3.64), osteomyelitis (2.9), neurological disorders (2.22), aminoglycoside therapy (1.74) and clindamycin therapy (4.73) as independent predictors for MRSA SSTIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.
- NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_assertion evidence source_evidence_literature NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.
- NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_assertion SIO_000772 19782432 NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.
- NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_assertion wasDerivedFrom befree-20140225 NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.
- NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_assertion wasGeneratedBy ECO_0000203 NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP718267.RAbM88U1H1zmjHk0xExSEX-s8RPV5jwyQyyvpF5TcsNFY130_provenance.